Literature DB >> 18187181

Identification of platelet-derived growth factor D in human chronic allograft nephropathy.

Gang Liu1, Siribha Changsirikulchai, Kelly L Hudkins, Miriam C Banas, Jolanta Kowalewska, Xiangling Yang, Tomasz A Wietecha, John Volpone, Debra G Gilbertson, Charles E Alpers.   

Abstract

Chronic allograft nephropathy (CAN), a descriptive term denoting chronic scarring injury of the renal parenchyma and vasculature in allograft kidneys arising from various etiologies including chronic rejection, is the most common cause of late allograft failure, but mediators of this progressive injury largely remain unknown. We hypothesized that platelet-derived growth factor D (PDGF-D) and its specific receptor PDGF-Rbeta may be an important mediator in the pathogenesis of CAN and, hence, sought to identify its expression in this setting. Allograft nephrectomies demonstrating CAN, obtained from patients with irreversible transplant kidney failure (n = 15), were compared with renal tissues without prominent histopathological abnormalities (n = 18) and a series of renal allograft biopsies demonstrating acute vascular rejection (AVR) (n = 12). Antibodies to PDGF-D and PDGF-Rbeta were used for immunohistochemistry. Double and triple immunohistochemistry was used to identify cell types expressing PDGF-D. PDGF-D was widely expressed in most neointimas in arteries exhibiting the chronic arteriopathy of CAN and only weakly expressed in a small proportion of sclerotic arteries in the other 2 groups. Double and triple immunolabeling demonstrated that the neointimal cells expressing PDGF-D were alpha-smooth muscle actin-expressing cells, but not infiltrating macrophages or endothelial cells. PDGF-Rbeta expression evaluated in serial sections was localized to the same sites where neointimal PDGF-D was expressed. PDGF-Rbeta was expressed in interstitial cells more abundantly in the CAN group compared with the normal and AVR groups, without demonstrable colocalization of PDGF-D. PDGF-D is present in the neointima of the arteriopathy of CAN, where it can engage PDGF-Rbeta to promote mesenchymal cell migration, proliferation, and neointima formation. PDGF-D may engage the PDGF-Rbeta to promote interstitial injury in chronic allograft injury, but its sources within the interstitium were unidentified.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18187181      PMCID: PMC2703673          DOI: 10.1016/j.humpath.2007.07.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  34 in total

1.  Platelet-derived growth factor-B induces transformation of fibrocytes into spindle-shaped myofibroblasts in vivo.

Authors:  S J Oh; H Kurz; B Christ; J Wilting
Journal:  Histochem Cell Biol       Date:  1998-04       Impact factor: 4.304

2.  Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats.

Authors:  Jens Lutz; Yousheng Yao; Erwei Song; Balazs Antus; Peter Hamar; Shanying Liu; Uwe Heemann
Journal:  Transplantation       Date:  2005-03-27       Impact factor: 4.939

3.  Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation.

Authors:  R B Colvin; A H Cohen; C Saiontz; S Bonsib; M Buick; B Burke; S Carter; T Cavallo; M Haas; A Lindblad; J C Manivel; C C Nast; D Salomon; C Weaver; M Weiss
Journal:  J Am Soc Nephrol       Date:  1997-12       Impact factor: 10.121

4.  Osteopontin expression in fetal and mature human kidney.

Authors:  K L Hudkins; C M Giachelli; Y Cui; W G Couser; R J Johnson; C E Alpers
Journal:  J Am Soc Nephrol       Date:  1999-03       Impact factor: 10.121

Review 5.  Chronic allograft nephropathy: An update.

Authors:  L C Paul
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

6.  Expression of PDGF alpha-receptor in renal arteriosclerosis and rejecting renal transplants.

Authors:  J Floege; K L Hudkins; C L Davis; S M Schwartz; C E Alpers
Journal:  J Am Soc Nephrol       Date:  1998-02       Impact factor: 10.121

7.  PDGF-D contributes to neointimal hyperplasia in rat model of vessel injury.

Authors:  Jingzhou Chen; Yu Han; Chunxia Lin; Yisong Zhen; Xiaodong Song; Siyong Teng; Chen Chen; Yu Chen; Yinhui Zhang; Rutai Hui
Journal:  Biochem Biophys Res Commun       Date:  2005-04-15       Impact factor: 3.575

8.  The Banff 97 working classification of renal allograft pathology.

Authors:  L C Racusen; K Solez; R B Colvin; S M Bonsib; M C Castro; T Cavallo; B P Croker; A J Demetris; C B Drachenberg; A B Fogo; P Furness; L W Gaber; I W Gibson; D Glotz; J C Goldberg; J Grande; P F Halloran; H E Hansen; B Hartley; P J Hayry; C M Hill; E O Hoffman; L G Hunsicker; A S Lindblad; Y Yamaguchi
Journal:  Kidney Int       Date:  1999-02       Impact factor: 10.612

9.  Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis.

Authors:  W W Tang; T R Ulich; D L Lacey; D C Hill; M Qi; S A Kaufman; G Y Van; J E Tarpley; J S Yee
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

10.  Ulex europaeus I lectin as a marker for vascular endothelium in human tissues.

Authors:  H Holthöfer; I Virtanen; A L Kariniemi; M Hormia; E Linder; A Miettinen
Journal:  Lab Invest       Date:  1982-07       Impact factor: 5.662

View more
  6 in total

Review 1.  Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease.

Authors:  Helena M Kok; Lucas L Falke; Roel Goldschmeding; Tri Q Nguyen
Journal:  Nat Rev Nephrol       Date:  2014-10-14       Impact factor: 28.314

2.  Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation.

Authors:  Anil Kumar; Xu Hou; Chunsik Lee; Yang Li; Arvydas Maminishkis; Zhongshu Tang; Fan Zhang; Harald F Langer; Pachiappan Arjunan; Lijin Dong; Zhijian Wu; Linda Y Zhu; Lianchun Wang; Wang Min; Peter Colosi; Triantafyllos Chavakis; Xuri Li
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

3.  VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients.

Authors:  Sang Hoon Song; In Gab Jeong; Dalsan You; Jun Hyuk Hong; Bumsik Hong; Cheryn Song; Woon Yong Jung; Young Mee Cho; Hanjong Ahn; Choung-Soo Kim
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 4.  The PDGF family in renal fibrosis.

Authors:  Tammo Ostendorf; Frank Eitner; Jürgen Floege
Journal:  Pediatr Nephrol       Date:  2011-05-21       Impact factor: 3.714

Review 5.  Platelet-derived growth factors (PDGFs) in glomerular and tubulointerstitial fibrosis.

Authors:  Tammo Ostendorf; Peter Boor; Claudia R C van Roeyen; Jürgen Floege
Journal:  Kidney Int Suppl (2011)       Date:  2014-11

Review 6.  Biological pathways and potential targets for prevention and therapy of chronic allograft nephropathy.

Authors:  Badri Man Shrestha; John Haylor
Journal:  Biomed Res Int       Date:  2014-05-27       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.